Innospec Inc Valuation – April 2018 $IOSP

Company Profile (excerpt from Reuters): Innospec Inc., incorporated on January 13, 2006, is a specialty chemicals company. The Company is engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives. Its Oilfield Services business supplies drilling, completion and production chemicals. Its other specialty chemicals provide technology-based solutions. Its Octane Additives business manufactures a fuel additive for use in automotive gasoline and provides services in respect of environmental remediation.

IOSP Chart

IOSP data by YCharts


Downloadable PDF version of this valuation:

ModernGraham Valuation of IOSP – April 2018

Stage 1: Is this company suitable for the Defensive Investor or the Enterprising Investor?

What kind of Intelligent Investor are you?

Defensive Investor; must pass 6 out of the following 7 tests.
1. Adequate Size of the Enterprise Market Cap > $2Bil $1,647,087,682 Fail
2. Sufficiently Strong Financial Condition Current Ratio > 2 2.15 Pass
3. Earnings Stability Positive EPS for 10 years prior Pass
4. Dividend Record Dividend Payments for 10 years prior Fail
5. Earnings Growth Increase of 33% in EPS in past 10 years using 3 year averages at beginning and end 97.09% Pass
6. Moderate PEmg Ratio PEmg < 20 18.63 Pass
7. Moderate Price to Assets PB Ratio < 2.5 OR PB*PEmg < 50 2.07 Pass
Enterprising Investor; must pass 4 out of the following 5 tests, or be suitable for the Defensive Investor.
1. Sufficiently Strong Financial Condition Current Ratio > 1.5 2.15 Pass
2. Sufficiently Strong Financial Condition Debt to NCA < 1.1 0.68 Pass
3. Earnings Stability Positive EPS for 5 years prior Pass
4. Dividend Record Currently Pays Dividend Pass
5. Earnings Growth EPSmg greater than 5 years ago Pass


Stage 2: Determination of Intrinsic Value

EPSmg $3.64
MG Growth Estimate 3.22%
MG Value $54.42
Opinion Overvalued
MG Grade C
MG Value based on 3% Growth $52.85
MG Value based on 0% Growth $30.98
Market Implied Growth Rate 5.06%
Current Price $67.90
% of Intrinsic Value 124.78%

Innospec Inc. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the small size, poor dividend history. The Enterprising Investor has no initial concerns. As a result, all Enterprising Investors following the ModernGraham approach should feel comfortable proceeding with the analysis.

As for a valuation, the company appears to be Overvalued after growing its EPSmg (normalized earnings) from $3 in 2014 to an estimated $3.64 for 2018. This level of demonstrated earnings growth does not support the market’s implied estimate of 5.06% annual earnings growth over the next 7-10 years. As a result, the ModernGraham valuation model, based on the Benjamin Graham value investing formula, returns an estimate of intrinsic value below the price.

At the time of valuation, further research into Innospec Inc. revealed the company was trading above its Graham Number of $56.41. The company pays a dividend of $0.77 per share, for a yield of 1.1% Its PEmg (price over earnings per share – ModernGraham) was 18.63, which was below the industry average of 29.39, which by some methods of valuation makes it one of the most undervalued stocks in its industry. Finally, the company was trading above its Net Current Asset Value (NCAV) of $-2.26.

Innospec Inc. receives an average overall rating in the ModernGraham grading system, scoring a C.

Stage 3: Information for Further Research

Net Current Asset Value (NCAV) -$2.26
Graham Number $56.41
PEmg 18.63
Current Ratio 2.15
PB Ratio 2.07
Current Dividend $0.77
Dividend Yield 1.13%
Number of Consecutive Years of Dividend Growth 5

Useful Links:

ModernGraham tagged articles Morningstar
Google Finance MSN Money
Yahoo Finance Seeking Alpha
GuruFocus SEC Filings

Most Recent Balance Sheet Figures

Balance Sheet Information 12/1/2017
Total Current Assets $561,500,000
Total Current Liabilities $261,600,000
Long-Term Debt $202,600,000
Total Assets $1,410,200,000
Intangible Assets $525,100,000
Total Liabilities $616,300,000
Shares Outstanding (Diluted Average) 24,237,000

Earnings Per Share History

EPS History
Next Fiscal Year Estimate $4.30
Dec2017 $2.52
Dec2016 $3.33
Dec2015 $4.86
Dec2014 $3.38
Dec2013 $3.22
Dec2012 $2.81
Dec2011 $1.92
Dec2010 $2.97
Dec2009 $0.26
Dec2008 $0.51
Dec2007 $1.19
Dec2006 $0.45
Dec2005 -$5.00
Dec2004 $0.24
Dec2003 $2.06
Dec2002 $2.08
Dec2001 $0.23
Dec2000 $0.71
Dec1999 $1.53
Dec1998 $2.43

Earnings Per Share – ModernGraham History

EPSmg History
Next Fiscal Year Estimate $3.64
Dec2017 $3.37
Dec2016 $3.70
Dec2015 $3.67
Dec2014 $3.00
Dec2013 $2.62
Dec2012 $2.11
Dec2011 $1.63
Dec2010 $1.35
Dec2009 $0.19
Dec2008 -$0.07
Dec2007 -$0.31
Dec2006 -$0.72
Dec2005 -$0.90
Dec2004 $1.12
Dec2003 $1.48
Dec2002 $1.26

Recommended Reading:

Other ModernGraham posts about the company

10 Stocks for Using A Benjamin Graham Value Investing Strategy – January 2017
8 Best Stocks for Value Investors This Week – 12/27/16
Innospec Inc Valuation – Initial Coverage $IOSP

Other ModernGraham posts about related companies

Innophos Holdings Inc Valuation – March 2018 $IPHS
Olin Corp Valuation – March 2018 $OLN
A Schulman Inc Valuation – March 2018 $SHLM
FMC Corp Valuation – March 2018 $FMC
Compass Minerals International Inc Valuation – March 2018 $CMP
Ashland Global Holdings Inc Valuation – March 2018 $ASH
Air Products & Chemicals Inc Valuation – March 2018 $APD
Koppers Holdings Inc Valuation – March 2018 $KOP
Kraton Corp Valuation – March 2018 $KRA
Quaker Chemical Corp Valuation – March 2018 $KWR


The author did not hold a position in any company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours.  See my current holdings here.  This article is not investment advice; any reader should speak to a registered investment adviser prior to making any investment decisions.  ModernGraham is not affiliated with the company in any manner.  Please be sure to review our detailed disclaimer.






Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.